Skip to content

Clinical trials

Recruiting Immunologic Deficiency Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunologic Deficiency Syndromes Status: Recruiting Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20092
20102
20121
20132
20141
20152
20171
20212
20221
20231
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)9
National Cancer Institute (NCI)4
Children's Hospital of Philadelphia2
Columbia University1
Henry M. Jackson Foundation for the Advancement of Military Medicine1
Icahn School of Medicine at Mount Sinai1
Institut National de la Santé Et de la Recherche Médicale, France1
Masonic Cancer Center, University of Minnesota1
Monica Bhatia1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunologic Deficiency Syndromes25
Autoimmune Diseases5
Infections4
Immune System Diseases3
Myelodysplastic Syndromes3
Primary Immunodeficiency Diseases3
Adenoviridae Infections2
Anemia, Aplastic2
Anemia, Refractory, with Excess of Blasts2
Asthma2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.